Results of New Peanut Allergy Trials Presented at EAACI Meeting
Results of New Peanut Allergy Trials Presented at EAACI Meeting
July 8th, 2015
The European Academy of Allergy and Clinical Immunology (EAACI) recently held its 2015 Annual Congress in Barcelona, Spain. FARE CEO Dr. James R. Baker, Jr. and FARE SVP of Research and Operations Mary Jane Marchisotto, attended the meeting, where new research findings about food allergies were presented. Of interest to the food allergy community, results of studies conducted by DBV Technologies and Aimmune Therapeutics were presented.